Abstract: An açai berry seed extract (açai palm fruit, Euterpe oleracea) and a process for obtaining the seed extract is provided which has an effect in the treatment of diseases or disorders individually or jointly related to the metabolic syndrome. A process is also provided for obtaining an açai berry seed extract or a fraction thereof, and a pharmaceutical and a food composition is provided for treating diseases or disorders individually or jointly related to the metabolic syndrome. A method for treating diseases or disorders individually or jointly associated with metabolic syndrome in humans or animals is also provided.

Abstract: Açaí berry seed extracts (açai palm fruit, Euterpe oleracea) with effect in the treatment of diseases or disorders individually or jointly related to the metabolic syndrome; a process for obtaining an açai berry seed extract; a pharmaceutical and a food composition for treating diseases or disorders individually or jointly related to the metabolic syndrome, and a method for treating diseases or disorders individually or jointly associated with metabolic syndrome in humans or animals.

Abstract: The present invention broadly relates to the use of certain ingenol derivatives as HIV reactivators of latent HIV virus in viral reservoirs. In another aspect, the present invention relates to an association comprising such ingenol derivatives and antiretroviral agents substantially active against actively replicating virus.

Abstract: Mulateiro is a plant, which is found in the Amazon, various extracts of which are used in traditional ethnic medicine. Describes are an extract of Mulateiro bark and its components, as well as their use for preventing hair loss and promoting hair growth. The major components of the extract were identified as isomers of chlorogenic acid and secoiridoids glucosides.

Abstract: The present invention relates to new ingenol derivative compounds for inhibiting cancer cell viability and treating cancer. In other aspects, the invention relates to a pharmaceutical composition, a medicament, methods for treating cancer, and a dosage form.

Abstract: The present invention relates to new ingenol derivative compounds for inhibiting cancer cell viability and treating cancer. In other aspects, the invention relates to a pharmaceutical composition, a medicament, methods for treating cancer, and a dosage form.

Abstract: The present invention refers to an active moiety of Paullinia cupana with enhanced activity against fatigue. Particularly related to cancers, and its manufacturing process, pharmaceutical compositions and drugs containing the same. Another object of the present invention is a method for treating fatigue, particularly related to cancers.

Abstract: The invention generally refers to pharmaceutical uses of lanosta-8,24-dien-3-ols, a family of tetracyclic terpenols, as anti-inflammatory, anticancerigenous and analgesic agents via the inhibition of the disordered activation of serine-threonine protein kinases, particularly PKC.

Abstract: The present invention relates to new ingenol derivative compounds for treating cancer. In other aspects, the invention relates to a pharmaceutical composition, medicament, method for treating cancer and dosage form.

Abstract: The present invention broadly relates to the use of certain ingenol derivatives as HIV reactivators of latent HIV virus in viral reservoirs. In another aspect, the present invention relates to an association comprising such ingenol derivatives and antiretroviral agents substantially active against actively replicating virus.

Abstract: The present invention relates to deodorant and antiperspirant compositions containing a natural active principle, containing tannins in the formulation. These compositions are suitable for use in all cosmetic formulations, such as sticks, aerosols, sprays and creams. The invention further relates to processes for production of deodorant and antiperspirant compositions, and to a method for prevention and/or reduction of perspiration odors.

Abstract: The present invention refers to an active moiety of Paullinia cupana with enhanced activity against fatigue. Particularly related to cancers, and its manufacturing process, pharmaceutical compositions and drugs containing the same. Another object of the present invention is a method for treating fatigue, particularly related to cancers.

Abstract: The present invention concern the use of isoquinoline alkaloid compounds of formula I in the preparation of pharmaceutical compositions useful in the treatment of neurodegenerative diseases, particularly Alzheimer's disease, as well as pharmaceutical composition comprising said compounds and method of treatment of neurodegenerative diseases wherein R1 is —OH or —OCH3, and X is non-existent, HCl or HBr, including their isomers,

Abstract: This invention refers to pharmaceutical use of multicyclic compounds chosen from ingenols, lanosta-8,24-dien-3-ols and their mixtures, as anti-AIDS agents.

Abstract: The invention generally refers to pharmaceutical uses of lanosta-8,24-dien-3-ols, a family of tetracyclic terpenols, as anti-inflammatory, anticancerigenous and analgesic agents via the inhibition of the disordered activation of serine-threonine protein kinases, particularly PKC.